Skip to main content
Eligibility
for people ages 55 years to 80 years
Location
at San Francisco, California
Dates
study started

Description

Summary

This study is a validation study to document the acceptability of the Tonic and Phasic Alertness Training (TAPAT) training program in older adults with chronic late-life insomnia. The goal of this study is to employ a computerized attention-training program, TAPAT, designed for chronic late-life insomnia in a randomized, controlled trial to assess feasibility and initial efficacy in this population.

Keywords

Insomnia

Eligibility

You can join if…

Open to people ages 55 years to 80 years

  • Participant must be between ages 55 and 80.
  • Participant must meet current diagnostic criteria for Primary Insomnia Disorder based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
  • Participant with hypertension must be undergoing treatment for this condition and on a stable medication regimen for hypertension for ≥ 8 weeks prior to screening.
  • Participant must be a fluent English speaker
  • Participant must have adequate visual, auditory, and motor capacity to use computerized intervention
  • Participant must be willing to wear Microsoft Band 2 watch to track sleep patterns

You CAN'T join if...

  • Participants with cognitive impairment, delirium or dementia, or evidence of cognitive impairment from a pre-existing cause.
  • Participants with untreated psychiatric conditions, including substance abuse/dependence disorders, untreated obstructive sleep apnea, diagnosis of other sleep disorders (e.g., restless legs syndrome), recent hospitalization, ongoing chemotherapy or other cancer treatment, and concurrent engagement in another insomnia treatment.
  • Participants enrolled in another concurrent research study.
  • Participants who have difficulty performing assessments or comprehending or following spoken instructions, in the judgment of the screening clinician.
  • Participants using computer-based cognitive training programs or has used them within a month of the consent date.

Location

  • Posit Science Corporation accepting new patients
    San Francisco, California, 94111, USA

Details

Status
accepting new patients
Start Date
Sponsor
Posit Science Corporation
ID
NCT02921074
Study Type
Interventional
Last Updated
October 2016
I'm interested in this study!